NICHOLAS SHELLEY: Open Payments
NPI 1215410220 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 21 payments from 12 companies in 2025. Trend: 2023 $684 · 2024 $813 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 4 | $78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $72 |
| ABBVIE INC. | 3 | $71 |
| Amgen Inc. | 2 | $62 |
| Corcept Therapeutics | 2 | $36 |
| Lilly USA, LLC | 1 | $23 |
| Mannkind Corporation | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $17 |
Products named: XYOSTED, JARDIANCE, EVENITY, SYNTHROID, Korlym, MOUNJARO, UBRELVY, AFREZZA.
Industry payments across FL — which companies pay providers there.
